Diagnostic Hybrids Inc. (DHI), The World’s Largest Cell Culture Provider,is engaged in the development, manufacture, and marketing of innovative molecular diagnostic products for clinical and research use, employing gene cloning, DNA probe, advanced cell culture and transgenic technology.